Header Logo

Connection

JOHN KIRKWOOD to Receptors, Platelet-Derived Growth Factor

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Receptors, Platelet-Derived Growth Factor.
JOHN KIRKWOOD
Connection Strength
0.389
Receptors, Platelet-Derived Growth Factor
  1. Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma. Clin Cancer Res. 2011 Dec 01; 17(23):7451-61.
    View in: PubMed
    Score: 0.389
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.